Literature DB >> 12689896

Infectious keratitis after photorefractive keratectomy.

Eric D Donnenfeld1, Terrence P O'Brien, Renée Solomon, Henry D Perry, Mark G Speaker, John Wittpenn.   

Abstract

PURPOSE: To elucidate risk factors, microbial culture results, and visual outcomes for infectious keratitis after photorefractive keratectomy (PRK).
DESIGN: Multicenter, retrospective chart review, case report, and literature review.
METHODS: The records of 12 patients with infectious keratitis after PRK were reviewed. MAIN OUTCOME MEASURES: Causative organism, response to medical treatment, and visual outcome.
RESULTS: Infectious keratitis developed in 13 eyes of 12 patients after PRK. Organisms cultured were Staphylococcus aureus (n = 5), including a bilateral case of methicillin-resistant Staphylococcus aureus; Staphylococcus epidermidis (n = 4); Streptococcus pneumoniae (n = 3); and Streptococcus viridans (n = 1). Four patients manipulated their contact lenses, and 2 patients were exposed to nosocomial organisms while working in a hospital environment. Prophylactic antibiotics used were tobramycin (nine cases), polymyxin B-trimethoprim (three cases), and ciprofloxacin (one case). Final best spectacle-corrected visual acuity ranged from 20/20 to 20/100.
CONCLUSIONS: Infectious corneal ulceration is a serious potential complication of PRK. Gram-positive organisms are the most common pathogens. Antibiotic prophylaxis should be broad spectrum and should include gram-positive coverage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12689896     DOI: 10.1016/S0161-6420(02)01936-X

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  11 in total

1.  Acute systemic immune activation following conjunctival exposure to staphylococcal enterotoxin B.

Authors:  Govindarajan Rajagopalan; Michele K Smart; Robin Patel; Chella S David
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

2.  Bilateral methicillin-resistant Staphylococcus aureus keratitis following hyperopic photorefractive surgery.

Authors:  Adriano Magli; Raimondo Forte; Luca Rombetto; Roberta Carelli
Journal:  Int Ophthalmol       Date:  2012-01-04       Impact factor: 2.031

3.  Moxifloxacin and cholesterol combined treatment of pneumococcal keratitis.

Authors:  Melissa E Sanders; Nathan A Tullos; Sidney D Taylor; Erin W Norcross; Lauren B King; Isaiah Tolo; Mary E Marquart
Journal:  Curr Eye Res       Date:  2010-12       Impact factor: 2.424

4.  Methicillin-resistant Staphylococcus aureus infections of the eye and orbit (an American Ophthalmological Society thesis).

Authors:  Preston Howard Blomquist
Journal:  Trans Am Ophthalmol Soc       Date:  2006

5.  Refractive surgery in the HIV-positive U.S. Military Natural History Study Cohort: complications and risk factors.

Authors:  Carter S Tisdale; Grant A Justin; Xun Wang; Xiuping Chu; Darrel K Carlton; Jason F Okulicz; Christina Schofield; Ryan C Maves; Brian K Agan; Gary L Legault
Journal:  J Cataract Refract Surg       Date:  2019-10-01       Impact factor: 3.351

6.  Post photorefractive keratectomy (PRK) infectious keratitis; six-year experience of a tertiary eye hospital.

Authors:  Mohammad Soleimani; Mohammad Keykhaei; Seyed Ali Tabatabaei; Mansoor Shahriari; Hossein Farrokhpour; Bahareh Ramezani; Kasra Cheraqpour
Journal:  Eye (Lond)       Date:  2022-03-10       Impact factor: 3.775

7.  Bilateral nocardia keratitis after photorefractive keratectomy.

Authors:  Amir Faramarzi; Sepehr Feizi; Mohammad-Ali Javadi; Mozhgan Rezaei Kanavi; Forouzan Yazdizadeh; Hamid-Reza Moein
Journal:  J Ophthalmic Vis Res       Date:  2012-04

8.  Nasal and conjunctival screening prior to refractive surgery: an observational and cross-sectional study.

Authors:  Koji Kitazawa; Chie Sotozono; Masako Sakamoto; Miho Sasaki; Osamu Hieda; Toshihide Yamasaki; Shigeru Kinoshita
Journal:  BMJ Open       Date:  2016-05-09       Impact factor: 2.692

9.  Staphylococcus aureus ocular infection: methicillin-resistance, clinical features, and antibiotic susceptibilities.

Authors:  Chih-Chun Chuang; Ching-Hsi Hsiao; Hsin-Yuan Tan; David Hui-Kang Ma; Ken-Kuo Lin; Chee-Jen Chang; Yhu-Chering Huang
Journal:  PLoS One       Date:  2012-08-07       Impact factor: 3.240

10.  A retrospective analysis of the postoperative use of loteprednol etabonate gel 0.5% following laser-assisted in situ keratomileusis or photorefractive keratectomy surgery.

Authors:  Clifford L Salinger; Michael Gordon; Mitchell A Jackson; Theodore Perl; Eric Donnenfeld
Journal:  Clin Ophthalmol       Date:  2015-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.